The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early clinical activity and pharmacodynamic effects of duvelisib, a PI3K-δ,γ inhibitor, in patients with treatment-naïve CLL.
 
Manish R. Patel
No Relationships to Disclose
 
Susan Mary O'Brien
Research Funding - Infinity Pharmaceuticals
 
Kerrie Faia
Employment - Infinity Pharmaceuticals
 
Kerry White
Employment - Infinity Pharmaceuticals
 
Mark Douglas
Employment - Infinity Pharmaceuticals
 
Kerstin Allen
Employment - Infinity Pharmaceuticals
 
Jeffrey Lorne Kutok
Employment - Infinity Pharmaceuticals
 
Jennifer Sweeney
Employment - Infinity Pharmaceuticals
Stock and Other Ownership Interests - Pfizer
 
Virginia Kelly
Employment - Infinity Pharmaceuticals; Takeda
Stock and Other Ownership Interests - Infinity Pharmaceuticals; Takeda
 
Ian Flinn
Consulting or Advisory Role - Infinity Pharmaceuticals
Research Funding - Infinity Pharmaceuticals
 
John C. Byrd
No Relationships to Disclose
 
Howard Stern
Employment - Infinity Pharmaceuticals